CFDA declaration for human TH1/TH2 subgroup
The first national multi factor reagent kit for human TH1/TH2 subgroup detection has been approved and officially entered the market
Cytokine series CD series products approved
Research and development of approved cytokine combined detection reagents for reproductive series, allergens, immunotherapy accompanied by diagnostic series, and other products
Awarded the "Top 10 Enterprises for Growth"
Awarded as a specialized, refined, innovative small and medium-sized enterprise in Jiangxi Province and a potential gazelle enterprise in Jiangxi Province
Alzheimer's disease joint testing kit approved
Hangzhou Saiji was established
Jiangxi Saiji was established, and the GMP factory passed the acceptance inspection
More than 200 users nationwide
Establishment of US R&D Center
Awarded National High tech Enterprise
Cytokine products were included in the Catalog of Urgent Medical Equipment for the Prevention and Treatment of COVID-19 (Third Batch)
PD-1 product exclusively approved nationwide
PD-1 product exclusively approved nationwide
Cytokine detection was included in the diagnosis and treatment scheme of novel coronavirus infection in major hospitals such as Xiehe and Huaxi. Inflammatory factors, concomitant factors and chemokines were approved
The new diagnostic technology and immunotherapy jointly applied by Zhejiang Engineering Research Center has been successfully approved and awarded the titles of Zhejiang Province Specialized, Refined, New, Small and Medium sized Enterprise and Jiangxi Province Gazelle Enterprise
